ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME. CMN [Internet]. 2024 Sep. 2 [cited 2025 Aug. 22];6(2):4972-83. Available from: http://cahiersmagellanes.com/index.php/CMN/article/view/782